JLE

Médecine de la Reproduction

MENU

Préservation de la fertilité féminine Volume 20, numéro 1, Janvier-Février-Mars 2018

  • [1] Institut national du cancer (INCa). Enquête. La vie deux ans après la cancer: de l’annonce à l’après cancer. Collection Études & Enquêtes, INCa, juin 2014.
  • [2] Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas. 1998;30:137-142.
  • [3] Mazur P., Seki S., Pinn I.L., Kleinhans F.W., Edashige K. Extra- and intracellular ice formation in mouse oocytes. Cryobiology. 2005;51:29-53.
  • [4] Practice Committee of American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2013;100:1214-1223.
  • [5] Donnez J., Dolmans M.M., Demylle D. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report. Hum Reprod. 2006;21:183-188.
  • [6] Chiarelli A.M., Marrett L.D., Darlington G.A. Pregnancy outcomes in females after treatment for childhood cancer. Epidemiology. 2000;11:161-166.
  • [7] Critchley H.O. Factors of importance for implantation and problems after treatment for childhood cancer. Med Pediatr Oncol. 1999;33:9-14.
  • [8] von Wolff M., Germeyer A., Nawroth F. Fertility preservation for non-medical reasons: controversial, but increasingly common. Dtsch Arztebl Int. 2015;112:27-32.
  • [9] Lawrenz B., Fehm T., von Wolff M. Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma--evaluation by using antimullerian hormone and retrieved oocytes. Fertil Steril. 2012;98:141-144.
  • [10] Dolmans M.M.D.D., Martinez-Madrid B., Donnez J. Efficacy of fertilization after chemotherapy. Fertil Steril. 2005;83:897-901. in vitro4
  • [11] Von Wolff M.T.C., Frambach T., Zeeb C., Lawrenz B., Popovici R.M., Strowitzki T. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril. 2009;4:1360-1365.
  • [12] Potdar N., Gelbaya T.A., Nardo L.G. Oocyte vitrification in the 21 century and post-warming fertility outcomes: a systematic review and meta-analysis. Reprod Biomed Online. 2014;29:159-176. st
  • [13] Cakmak H., Katz A., Cedars M.I., Rosen M.P. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertil Steril. 2013;100:1673-1680.
  • [14] Oktay K., Hourvitz A., Sahin G. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab. 2006;91:3885-3890.
  • [15] Rao G.D., Tan S.L. maturation of oocytes. Semin Reprod Med. 2005;23:242-247. In vitro
  • [16] Lee J.A., Sekhon L., Grunfeld L., Copperman A.B. maturation of germinal vesicle and metaphase I eggs prior to cryopreservation optimizes reproductive potential in patients undergoing fertility preservation. Curr Opin Obstet Gynecol. 2014;26:168-173. In vitro
  • [17] Chian R.C., Huang J.Y., Gilbert L. Obstetric outcomes following vitrification of and matured oocytes. Fertil Steril. 2009;91:2391-2398. in vitroin vivo
  • [18] Cobo A., Kuwayama M., Perez S., Ruiz A., Pellicer A., Remohi J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89:1657-1664.
  • [19] Yang B., Shi W., Yang J. Concurrent treatment with gonadotropin-releasing hormone agonists for chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a meta-analysis of randomized controlled trials. Breast. 2013;22:150-157.
  • [20] Practice Committee of American Society for Reproductive Medicine. Ovarian tissue cryopreservation: a committee opinion. Fertil Steril. 2014;101:1237-1243.
  • [21] Donnez J., Dolmans M.M., Pellicer A. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril. 2013;99:1503-1513.
  • [22] Morice P., Castaigne D., Haie-Meder C. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril. 1998;70:956-960.